Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others. According to our (Global Info Research) latest study, the global Transdermal Patch market size was valued at USD 6989.7 million in 2022 and is forecast to a readjusted size of USD 8859.9 million by 2029 with a CAGR of 3.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%. Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total. Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019. This report is a detailed and comprehensive analysis for global Transdermal Patch market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Transdermal Patch market size and forecasts, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/Pc), 2018-2029 Global Transdermal Patch market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/Pc), 2018-2029 Global Transdermal Patch market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/Pc), 2018-2029 Global Transdermal Patch market shares of main players, shipments in revenue ($ Million), sales quantity (M Pcs), and ASP (USD/Pc), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Transdermal Patch To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Transdermal Patch market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma and Mylan, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market Segmentation Transdermal Patch market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Methyl Salicylate-based Patch Rivastigmine Transdermal Patch Fentanyl Transdermal Patch Lidocaine Patch Diclofenac Patch Nicotine Transdermal Patch Others Market segment by Application Rx Channel OTC Channel Major players covered Hisamitsu Pharmaceutical Johnson & Johnson Novartis UCB Pharma Mylan Teva Pharmaceutical Nitto Denko Gr�nenthal IBSA Group GSK Luye Pharma Group Pfizer Chattem Dr Reddyﾒs Laboratories Bayer Mundipharma Endo International Beijing Tide Pharmaceutical Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Transdermal Patch product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Transdermal Patch, with price, sales, revenue and global market share of Transdermal Patch from 2018 to 2023. Chapter 3, the Transdermal Patch competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Transdermal Patch breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Transdermal Patch market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of Transdermal Patch. Chapter 14 and 15, to describe Transdermal Patch sales channel, distributors, customers, research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Transdermal Patch 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Transdermal Patch Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 Methyl Salicylate-based Patch 1.3.3 Rivastigmine Transdermal Patch 1.3.4 Fentanyl Transdermal Patch 1.3
